IL17F and inflammatory bowel disease: Despite the above data suggesting that IL-17A has anti-inflammatory effects in the gut, we cannot exclude the possibility that, under specific circumstances, this cytokine can cooperate with IL-17F and other Th17 or Th1 cytokines to expand the IBD-associated inflammatory response.